# Ustekinumab-aekn

NDC: 51759-413
Generic name: ustekinumab-aekn
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251223

FDA application: BLA761343

## Active ingredients

- USTEKINUMAB-AEKN: 45 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-413"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-413
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=052a3fb2-21c3-4c4e-a01e-afdd1accd1cd